Sort by
Refine Your Search
-
of data driven biomedical analysis and introduce you to the UK Biobank, a world leading research resource that is growing in scale and significance and is central to the UK’s biomedical data science
-
. This hypoxic environment has a profound influence on tumour biology, eliciting the expression of pro-survival pathways, immune tolerance and resistance to radiotherapy.1 Indeed, hypoxia is currently recognized
-
doctoral degree or who have been registered on a programme of research leading to the award of an MRes or doctoral degree are NOT eligible to apply for an award. Applicants who hold or who are registered
-
admission requirements may be offered admission on a self-funded basis. Applicants who already hold an MRes or a doctoral degree or who have been registered on a programme of research leading to the award
-
platforms for studying tumour biology and testing drug efficacy in a personalised context [4]. By using panels of genetically diverse prostate cancer cell lines, researchers can mimic the molecular spectrum
-
. Combining computer vision with artificial intelligence will enable a PhD researcher to develop models that can reason, understand or learn like a human. The ability to identify defects, adapt to new and
-
, including questionnaires and focus groups with pharmacists, the public and those working in the healthcare sector. Skills required of applicant: A degree in a science based subject area such as Biomedical
-
project with enhanced training and 3+ month placement, which is fully funded by UKRI BBSRC through the NI Landscape Partnership in AI for Bioscience (NILAB) Programme, delivered by Queen’s University
-
biomarker discovery pipeline. You will gain invaluable hands-on experience analysing large-scale, complex biomedical datasets and achieve proficiency using the UK Biobank – a vital skill for modern biomedical
-
Development of an docetaxel-loaded implantable device for the localised treatment of prostate cancer
drug delivery technology designed for the sustained release of chemotherapy directly into cancer tissue thereby improving clinical performance. Prostate cancer is one of the most common types of cancer